RiboPro
Latest round
- Series A
Last raised
- Oct 2024
Total raised
- Undisclosed
Investors
- 4
About RiboPro
RiboPro, founded in 2020 in the Netherlands, focuses on RNA-based therapeutics.RiboPro specializes in the development and manufacturing of messenger RNA (mRNA) and lipid nanoparticle (LNP) formulations aimed at advancing RNA-based therapeutics. Their core offerings encompass custom mRNA design, GMP-grade manufacturing, and formulation services, facilitating the creation of targeted mRNA therapeutics for various medical applications, including chronic kidney disease, eye diseases, and immunotherapy. RiboPro's technologies are utilized by a diverse clientele, including biopharma companies, research institutions, and health networks across multiple geographical markets, including Europe, the United States, Japan, and South Korea.RiboPro generates revenue through a business model that primarily involves direct partnerships with clients in the biopharmaceutical sector. Transactions are structured around the provision of custom mRNA and LNP formulations, with clients engaging RiboPro for both one-off projects and long-term collaborations that may include contract research and development agreements. The company’s revenue streams are derived from various services, including the manufacture of high-quality mRNA for research and therapeutic applications, which are sold to academic institutions, biotechnology firms, and healthcare organizations. Additionally, the pricing structure reflects the complexity and customization of the products, with clients benefiting from tailored services, priority manufacturing, and access to proprietary technologies. RiboPro aims to expand its product offerings with new mRNA formulations targeted for release by mid-2025, while also exploring growth opportunities in new geographical markets, including Asia and North America, by 2026.
Who invested in RiboPro
4 investors across 1 round
See all investors in RiboPro
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 31, 2024
Amount
Undisclosed
Investors
Questions about RiboPro
Who invested in RiboPro?
RiboPro has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RiboPro raised?
RiboPro has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did RiboPro last raise money?
RiboPro's most recent round on record is a Series A, in Oct 2024.
What does RiboPro do?
RiboPro, founded in 2020 in the Netherlands, focuses on RNA-based therapeutics.
Where is RiboPro headquartered?
RiboPro is headquartered in Netherlands.
Which VCs invest in companies like RiboPro?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biopolymers companies at RiboPro's stage. Their profiles are linked below.
VCs backing biopolymers startups at Series A
Raising like RiboPro? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.